Near-Patient Test for C-Reactive Protein in General Practice: Assessment of Clinical, Organizational, And Economic Outcomes (Test Utilization and Outcomes) (Clinical Report) Near-Patient Test for C-Reactive Protein in General Practice: Assessment of Clinical, Organizational, And Economic Outcomes (Test Utilization and Outcomes) (Clinical Report)

Near-Patient Test for C-Reactive Protein in General Practice: Assessment of Clinical, Organizational, And Economic Outcomes (Test Utilization and Outcomes) (Clinical Report‪)‬

Clinical Chemistry 1999, April, 45, 4

    • $5.99
    • $5.99

Publisher Description

C-reactive protein (CRP) [3] is an acute phase protein widely used for the diagnosis and follow-up of infectious diseases in hospitals (1-4). In general practice, CRP is found valuable in the diagnosis of bacterial diseases and in the differentiation between bacterial and viral infections (5-7). Often the diagnostic value of CRP is found superior to that of the erythrocyte sedimentation rate (ESR) (7-9) and superior or equal to that of the white blood cell count (WBC) (5, 8, 9). In Denmark, general practitioners (GPs) request CRP by mailing blood samples to hospital laboratories, and the test is ordered for 34% of all patients having a blood sample mailed (10). Several near-patient tests for CRP measurements are available commercially. We have evaluated one of these tests (NycoCard[R] CRP) and found it reliable and robust for the use in general practice (11). In questionnaire surveys, it has been proposed that knowing the CRP value while having the patient in the office may give GPs better guidance for the prescription of antibiotics than ESR (12,13).

GENRE
Science & Nature
RELEASED
1999
1 April
LANGUAGE
EN
English
LENGTH
25
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
235.9
KB
Immediate Availability of C-Reactive Protein and Leukocyte Count Data Influenced Physicians' Decisions to Prescribe Antimicrobial Drugs for New Outpatients with Acute Infections (Technical Briefs) Immediate Availability of C-Reactive Protein and Leukocyte Count Data Influenced Physicians' Decisions to Prescribe Antimicrobial Drugs for New Outpatients with Acute Infections (Technical Briefs)
2004
When to Collect Blood Specimens: Midmorning vs Fasting Samples (Laboratory and Management) When to Collect Blood Specimens: Midmorning vs Fasting Samples (Laboratory and Management)
1998
Impact of CK-MB Testing Policies on Hospital Length of Stay and Laboratory Costs for Patients with Myocardial Infarction Or Chest Pain (Test Utilization and Outcomes) Impact of CK-MB Testing Policies on Hospital Length of Stay and Laboratory Costs for Patients with Myocardial Infarction Or Chest Pain (Test Utilization and Outcomes)
1997
Tolerance, Safety and Efficacy of Hedera Helix Extract in Inflammatory Bronchial Diseases Under Clinical Practice Conditions: A Prospective, Open, Multicentre Postmarketing Study in 9657 Patients (Report) Tolerance, Safety and Efficacy of Hedera Helix Extract in Inflammatory Bronchial Diseases Under Clinical Practice Conditions: A Prospective, Open, Multicentre Postmarketing Study in 9657 Patients (Report)
2009
Pinimenthol[R] Ointment in Patients Suffering from Upper Respiratory Tract Infections--a Post-Marketing Observational Study (Report) Pinimenthol[R] Ointment in Patients Suffering from Upper Respiratory Tract Infections--a Post-Marketing Observational Study (Report)
2007
Statistical Issues in Drug Research and Development Statistical Issues in Drug Research and Development
2017
Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology) Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology)
1997
Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial) Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial)
2001
Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry) Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry)
2003
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs) Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs)
2002
Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report) Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report)
2007